Reexamination of the TEMPO study (multiple letters)

Archives of Neurology

Volumn 62, Issue 8, 2005, Pages 1320-1321

  Shults, Clifford W ^a   Siderowf, Andrew ^b   Eberly, Shirley ^c   Oakes, David ^c   Shoulson, Ira ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

RASAGILINE; SELEGILINE; TOCOPHEROL;

ANTIOXIDANT ACTIVITY; CLINICAL EXAMINATION; CLINICAL TRIAL; DISABILITY; DISEASE CLASSIFICATION; DOPAMINERGIC ACTIVITY; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANTIOXIDANTS; ANTIPARKINSON AGENTS; ARTIFACTS; DRUG INTERACTIONS; HUMANS; INDANS; MONOAMINE OXIDASE INHIBITORS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SELEGILINE; TREATMENT OUTCOME;

EID: 23844530259     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.8.1320     Document Type: Letter

References (0)